VIRGINIA CITY, Nev., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”), today announced that it has commenced an underwritten public offering for the sale of its common stock (or pre-funded warrants in lieu thereof). In connection with the offering, Comstock expects to grant the underwriter a 30-day option to purchase additional common stock in an amount up to 15% of the shares of common stock (or pre-funded warrants) offered in the offering, to cover over-allotments, if any. The pre-funded warrants will be immediately exercisable and may be exercised at any time until exercised in full. The Company intends to use the net proceeds from this offering for capital expenditures associated with commercializing its first industry scale facility for Comstock Metals, development expenses, and general corporate purposes, including the payment of existing indebtedness. The offering is subject to market conditions and other factors, and there can be no
Related Questions
What is the total size (in shares and dollar amount) of the primary public offering and the potential over‑allotment?
How will the issuance of pre‑funded warrants affect dilution and the capital structure of Comstock Inc.?
What price range will the shares (or pre‑funded warrants) be offered at, and how does that compare to the current market price?
What is the expected timeline for the closing of the offering and the exercise of the pre‑funded warrants?
What specific capital expenditures are planned for commercializing the first industry‑scale facility for Comstock Metals?
How will the net proceeds be allocated among development expenses, debt repayment, and general corporate purposes?
What is the current level of indebtedness and how will the repayment of existing debt impact the company’s balance sheet and credit metrics?
How does this capital raise compare to recent equity offerings by peer companies in the metals and mining sector?
What are the terms of the 30‑day option granted to the underwriter, and what is the likelihood of it being exercised?
How might the offering and potential over‑allotment affect the stock’s liquidity and short‑term price volatility?
Are there any lock‑up or registration rights agreements that could affect future secondary offerings or insider selling?